Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
Quick Stats
Jan 30, 202648.8
AI Score
HOLD0.69
Volume Ratio
Mar 10, 2026
Next Earnings
13
+ve Days (30d)
17
-ve Days (30d)
LYEL Stock Summary
Last updated Jan 30, 2026
LYEL is currently trading at $24, positioned above its 200-day moving average of $15.48, indicating a long-term uptrend. The stock has a 52-week range of $0.4 to $45.
Technical Analysis: The 50-day moving average stands at $26.9, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 42.111, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.29, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates LYEL at 48.8/100 with a HOLD recommendation.
LYEL (Lyell Immunopharma, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 42.111 |
| CMF (20) | -0.29 |
| ROC (10) | 4.666 |
| ADX (14) | 20.005 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.927 |
| AROONOSC (14) | 28.571 |
| WILLAMS %R (14) | -70.598 |
| MFI (14) | 50.485 |
LYEL Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
LYEL Price vs Max Options Open Interest
LYEL Max Change In Options Open Interest
LYEL Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LYEL Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LYEL Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LYEL Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Lyell Immunopharma, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
LYEL Moving Averages Analysis
Lyell Immunopharma, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
LYEL (Lyell Immunopharma, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 24.63 |
| 20 | 24.84 |
| 30 | 28.06 |
| 50 | 26.9 |
| 100 | 21.43 |
| 200 | 15.48 |
LYEL Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 510.5 million |
| Earnings/Share ($) | -22.75 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -10.6075 |
| EPS Estimate Next Year ($) | -9.0525 |
| WallStreet Target Price ($) | 29.6667 |
| Most Recent Quarter |